Evidence map›Paper›PMID 28630182›Full record

ArticleAntimicrobial agents and chemotherapy2017

Biodistribution and

Maryam Iman, Zhaohua Huang, Seyedeh Hoda Alavizadeh, Francis C Szoka, Mahmoud R Jaafari

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Maryam ImanChemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Zhaohua HuangDepartments of Bioengineering, Therapeutic Sciences, and Pharmaceutical Chemistry, School of Pharmacy, University of California at San Francisco, San Francisco, California, USA.
Seyedeh Hoda AlavizadehNanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Francis C SzokaDepartments of Bioengineering, Therapeutic Sciences, and Pharmaceutical Chemistry, School of Pharmacy, University of California at San Francisco, San Francisco, California, USA.
Mahmoud R JaafariBiotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran jafarimr@mums.ac.ir.
Mashhad University of Medical Sciences · IRUniversity of California, San Francisco · US

Funding

Targeted Drug Delivery to Surface Receptors.R01GM061851 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SZOKA, FRANCIS C. · 2001 to 2015
$3.5M
NIGMS NIH HHS R01 GM061851
6 · The paper itself

Abstract

1,2-Distigmasterylhemisuccinoyl-

Indexed as

Amphotericin BAnimalsAntiprotozoal AgentsDisease Models, AnimalDrug Administration RoutesDrug CarriersFemaleLeishmania majorLeishmaniasis, CutaneousLiposomesMiceMice, Inbred BALB CParasite LoadPhosphatidylcholinesSpleenStigmasterol1,2-distigmasterylhemisuccinoyl-glycero-3-phosphocholineAmphotericin BAntiprotozoal AgentsDrug Carriersliposomal amphotericin BLiposomesPhosphatidylcholinesStigmasterolamphotericin Bbiodistributiondistigmasteryl-modified phospholipidsleishmaniasisliposomes

Identifiers

PMID28630182
PMCPMC5571372
OpenAlexW2664102069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.